Synthes USA HQ, Inc.
12
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
41.7%
5 terminated/withdrawn out of 12 trials
58.3%
-28.2% vs industry average
8%
1 trials in Phase 3/4
143%
10 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
T1Rho MRI Evaluation of Patellofemoral Changes After Tibial IM Nailing
Role: collaborator
Outcome Study of Patients Treated With Translational Cervical Plate Used to Treat Degenerative Disc Disease
Role: lead
Lumbar Degenerative Disc Disease Treated With Anterior Tension Band System (ATB) With ALIF/FRA Spacer
Role: lead
Comparison of Cervical Laminectomy to Laminoplasty
Role: lead
Safety and Efficacy Study Comparing ProDisc-C to ACDF Surgery to Treat SCDD
Role: lead
Clinical Outcomes Study Evaluating the Zero-P PEEK
Role: lead
Clinical Outcomes of Lumbar Degenerative Disc Disease in Active-Duty U.S. Service Personnel
Role: lead
Prospective, Multi-Center Clinical Outcomes Study Evaluating the chronOS Strip Combined With Bone Marrow Aspirate
Role: lead
Safety and Effectiveness Study of Prodisc to Spinal Fusion Surgery
Role: lead
A Study of the In-Space Device for Treatment of Moderate Spinal Stenosis
Role: lead
Study of SyntheCelTM Dura Replacement to Other Dura Replacements
Role: lead
Physical Capability Outcomes After Single-Level PD-L vs Single-Level ALIF: a Multi-Center Clinical Trial
Role: collaborator
All 12 trials loaded